Jul 10, 2023 08:03AM

Jul 10, 2023 08:00AM

Jun 27, 2023 08:06AM

Jun 27, 2023 08:05AM

Jun 27, 2023 08:00AM

Jun 27, 2023 08:00AM

Jan 18, 2023 07:01AM Paratek Pharmaceuticals (PRTK) Announces Inclusion of NUZYRA® (omadacycline) in China’s National Reimbursement Drug List

Jan 18, 2023 07:00AM

Jan 5, 2023 08:03AM

Jan 5, 2023 08:00AM

Dec 19, 2022 07:31AM

Dec 19, 2022 07:30AM

Oct 31, 2022 08:00AM

Aug 3, 2022 04:05PM Paratek Pharmaceuticals Announces Second Quarter 2022 Revenue of $29.6 Million

Jun 22, 2022 06:08AM

Jun 21, 2022 04:33PM

Jun 21, 2022 04:05PM

Jun 21, 2022 04:05PM

Mar 8, 2022 04:06PM

Mar 8, 2022 04:05PM

Mar 1, 2022 04:05PM Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member

Mar 1, 2022 04:05PM

Dec 16, 2021 11:57AM

Dec 16, 2021 11:36AM

Nov 8, 2021 04:05PM

Oct 18, 2021 04:05PM

Sep 27, 2021 04:06PM

Sep 27, 2021 04:05PM Paratek Pharmaceuticals Announces Additional Funding Under the BARDA Contract to Advance the Development of NUZYRA® (omadacycline) for Post-Exposure Prophylaxis (PEP) and Treatment of Pulmonary Anthr

Sep 23, 2021 04:05PM

Aug 18, 2021 04:13PM

Aug 18, 2021 04:12PM

Aug 9, 2021 04:05PM

Aug 5, 2021 08:00AM

Aug 4, 2021 04:36PM

Aug 4, 2021 04:30PM Paratek Pharmaceuticals Announces NUZYRA® (omadacycline) Has Been Added to the CDC Plague Guidelines for the Treatment, Pre-Exposure and Postexposure Prophylaxis of Plague

Jun 29, 2021 08:00AM

Jun 16, 2021 07:34AM

Jun 16, 2021 07:30AM

Jun 14, 2021 08:00AM

Jun 10, 2021 08:00AM

Jun 8, 2021 11:18AM

Jun 1, 2021 04:05PM Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Jun 1, 2021 07:46AM

Jun 1, 2021 07:45AM

May 17, 2021 07:30AM

Feb 24, 2021 04:01PM

Feb 17, 2021 10:04AM

Feb 8, 2021 08:00AM

Jan 6, 2021 08:00AM Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference

Nov 12, 2020 04:01PM

322,095 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All